Ryan Weispfenning | VP and Head of IR |
Geoff Martha | Chairman and CEO |
Karen Parkhill | CFO |
Brad Welnick | VP, IR |
Que Dallara | EVP and President, Diabetes |
Mike Marinaro | EVP and President, Surgical and Endoscopy |
Sean Salmon | EVP and President, Cardiovascular |
Vijay Kumar | Evercore ISI |
Robbie Marcus | JPMorgan |
Larry Biegelsen | Wells Fargo Securities |
Danielle Antalffy | UBS |
Travis Steed | Bank of America |
Matt Miksic | Barclays |
Chris Pasquale | Nephron |
Jayson Bedford | Raymond James |
Joanne Weunsch | Citi |
Patrick Wood | Morgan Stanley |
Good morning, I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. I appreciate that you're joining us today for our Fiscal 2024 First Quarter Video Earnings Webcast. We're broadcasting to you today from our operational headquarters here in Minnesota where summer is in full force.
Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast.
Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer.